Connection
Peter Pressman to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Peter Pressman has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
0.313 |
|
|
|
-
Pressman P, Gottfried JA. Journal Club: a randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 2012 Jul 24; 79(4):e33-6.
Score: 0.313